Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
65 participants
OBSERVATIONAL
2017-01-01
2019-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
NCT02807350
A Pilot Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
NCT02223650
Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents
NCT06927414
Effect of Light-Blocking Lenses on Pediatric Hyperopia
NCT07142915
3D Designed Defocus Lenses on Myopia Control in Children and Adolescents
NCT07284147
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Materials and Method: Sixty-five consecutive cases of IXT followed for at least 48 months were included. Patients with a history of previous surgery, ocular pathology, convergence insufficiency, severe myopia (\>-5.0 D), severe hyperopia (\>+5.0 D), moderate or severe amblyopia and poor compliance with spectacles were excluded. Data was collected including near stereoacuity, AC/A ratio, control of IXT measured with Newcastle Control Score (NCS) at baseline and in all follow-up visits. Baseline values without overminus threapy were compared with postintervention values at every visit.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Myopic overcorrection
Myopic overcorrection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* prescribed overminus lenses
Exclusion Criteria
* convergence insufficiency type IXT
* presence of any type of ocular deviation except IXT
* presence of severe myopia (greater than -5.0 D)
* presence of severe hyperopia (greater than +5.0 D)
* presence of moderate or severe amblyopia
* poor compliance with overminus spectacles
* follow up period of \<48 months after intervention.
3 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elif Demirkilinc Biler
Assoc. Prof., M.D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ege University Faculty of Medicine
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ege30042919
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.